Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2,3-oxidosqualene-lanosterol cyclase inhibitors

2,3-oxidosqualene-lanosterol cyclase inhibitors

US Patent 6858651 · Granted Feb 22, 2005

Estimated economic value: $72,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Synthesis of trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dih2025
Process for the preparation of substituted pyrazole derivatives2025
Drug-conjugates, conjugation methods, and uses thereof2024
Drug-conjugates with a targeting molecule and two different drugs2024
Difluoroketamide derivatives as HtrA1 inhibitors2021
Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihy2021
Process for GalNAc oligonucleotide conjugates2021
Trifluoromethylpropanamide derivatives as HTRA1 inhibitors2021
Difluoroketamide derivatives as HTRA1 inhibitors2021
Drug-conjugates, conjugation methods, and uses thereof2021
Trifluoromethylpropanamide derivatives as HTRA1 inhibitors2020
Difluoroketamide derivatives as HtrA1 inhibitors2020